日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The association between vaccine coverage and herd protection: exploratory analyses of a cluster-randomised trial of Vi conjugate vaccine

疫苗接种率与群体免疫之间的关联:一项Vi结合疫苗整群随机试验的探索性分析

McKee, Geoffrey; Butt, Zahid A; Wong, Stanley; Salway, Travis; Gilbert, Mark; Wong, Jason; Alvarez, Maria; Chapinal, Nuria; Darvishian, Maryam; Tyndall, Mark W; Krajden, Mel; Janjua, Naveed Z; Zhang, Yiyuan; Ahmmed, Faisal; Khanam, Farhana; Biswas, Prasanta Kumar; Mujadidi, Yama F; Kelly, Sarah; Qadri, Firdausi; Clemens, John D; Pollard, Andrew J; Liu, Xinxue

Immunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil

ChAdOx1 nCoV-19 (AZD1222) 作为同源第四剂加强针的免疫原性和安全性:巴西 3 期 COV003 试验的子研究

Costa Clemens, Sue Ann; Bibi, Sagida; Marchevsky, Natalie G; Aley, Parvinder K; Cappuccini, Federica; Davies, Sophie A; Gonzalez, Isabela; Kelly, Sarah C; Mujadidi, Yama F; Pipolo Milan, Eveline; Schwarzbold, Alexandre V; Sprinz, Eduardo; Voysey, Merryn; Weckx, Lily Y; Wright, Daniel; Bansal, Himanshu; Bergagård, Maria A S; Isaacs, Abby J; Kelly, Elizabeth J; Lan, Dongmei; Morgan, Shethah; Shankar, Nirmal Kumar; Shoemaker, Kathryn; Villafana, Tonya L; Lambe, Teresa; Green, Justin A; Pollard, Andrew J

Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa

HIV-CORE 006 研究:在东非和南部非洲健康成年人中开展的一项双盲、随机、安慰剂对照的 1 期临床试验,评估了由 ChAdOx1 和 MVA 载体递送的 HIVconsvX 保守嵌合候选 T 细胞疫苗的安全性和广泛免疫原性。

Chanda, Chama; Kibengo, Freddie; Mutua, Michael; Ogada, Fred; Muturi-Kioi, Vincent; Akis Yildirim, Belkis M; Amondi, Mary; Baines, Andrea; Basajja, Vincent; Borthwick, Nicola; Bosire, Kefa; Chambula, Elias; Chetty, Paramesh; Chinyenze, Kundai; Chirro, Oscar; Crook, Alison; De Bont, Jan; Fernandez, Natalia; Ejou, Peter; Farah, Bashir; Glaze, Molly; Gombe, Ben; Gumbe, Anne; Hayes, Peter; Itwi, Sally; Juma, Sheba; Kabarambi, Anita; Kabengele, Chishiba; Kafeero, Paddy; Kakande, Ayoub; Kanungi, Jennifer; Kidega, William; King, Deborah; Mahira, Rose; Malogo, Roselyn; Matsoso, Mabela; Michelo, Clive; Moyo, Annie; Mugaba, Susan; Mugenya, Irene; Muhumuza, Patrick; Mujadidi, Yama F; Muriuki, Moses; Musale, Vernon; Mutua, Gaudensia; Muwowo, Meya; Mwale, Fatima; Mwangi, Irene; Nakimbugwe, Maria; Namuyanja, Angella; Nduati, Eunice; Nielsen, Leslie; Nyange, Jaquelyn; Oino, Geofrey; Okech, Brenda; Omosa-Manyonyi, Gloria; Otieno, Dan; Palmer, Shaun; Phiri, Hilda; Ramko, Kelly; Rutishauser, Rachel L; Sayeed, Eddy; Sajabi, Rose; Serwanga, Jennifer; G-T Wee, Edmund; Wenden, Claire; Cicconi, Paola; Fast, Patricia; Gilmour, Jill; Jaoko, Walter; Kaleebu, Pontiano; Kilembe, William; Kuipers, Hester; Sanders, Eduard J; Hanke, Tomáš

Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines

Com-COV2 研究中异源 COVID 疫苗接种方案的免疫反应持久性——一项包含 mRNA 疫苗、病毒载体疫苗和蛋白佐剂疫苗的单盲随机试验

Shaw, Robert H; Greenland, Melanie; Stuart, Arabella S V; Aley, Parvinder K; Andrews, Nick J; Cameron, J Claire; Charlton, Sue; Clutterbuck, Elizabeth A; Collins, Andrea M; Darton, Tom; Dinesh, Tanya; Duncan, Christopher J A; Faust, Saul N; Ferreira, Daniela M; Finn, Adam; Goodman, Anna L; Green, Christopher A; Hallis, Bassam; Heath, Paul T; Hill, Helen; Lambe, Teresa; Libri, Vincenzo; Lillie, Patrick J; Morey, Ella; Mujadidi, Yama F; Payne, Ruth; Plested, Emma L; Provstgaard-Morys, Samuel; Ramasamy, Maheshi N; Ramsay, Mary; Read, Robert C; Robinson, Hannah; Screaton, Gavin R; Singh, Nisha; Turner, David P J; Turner, Paul J; White, Rachel; Nguyen-Van-Tam, Jonathan S; Liu, Xinxue; Snape, Matthew D

Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511]

对“在英国接种两剂 ChAdOx1 nCov-19 或 BNT162b2 后,作为第三剂加强针接种的七剂 COVID-19 疫苗的免疫原性持久性:COV-BOOST 试验的三个月分析”的更正 [J Infect 84(6) (2022) 795-813, 5511]

Liu, Xinxue; Munro, Alasdair Ps; Feng, Shuo; Janani, Leila; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dejnirattisai, Wanwisa; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A; Kwok, Jonathan; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Serafimova, Teona; Saralaya, Dinesh; Screaton, Gavin R; Sharma, Sunil; Sheridan, Ray; Sturdy, Ann; Supasa, Piyada; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Cornelius, Victoria; Snape, Matthew D; Faust, Saul N

Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial

青少年接种异源或部分剂量 COVID-19 第二剂疫苗后的反应原性、免疫原性和突破性感染(Com-COV3):一项随机对照试验

Kelly, Eimear; Greenland, Melanie; de Whalley, Philip C S; Aley, Parvinder K; Plested, Emma L; Singh, Nisha; Koleva, Stanislava; Tonner, Sharon; Macaulay, Grace C; Read, Robert C; Ramsay, Mary; Cameron, J Claire; Turner, David P J; Heath, Paul T; Bernatoniene, Jolanta; Connor, Philip; Cathie, Katrina; Faust, Saul N; Banerjee, Indraneel; Cantrell, Liberty; Mujadidi, Yama F; Belhadef, Hanane Trari; Clutterbuck, Elizabeth A; Anslow, Rachel; Valliji, Zara; James, Tim; Hallis, Bassam; Otter, Ashley David; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Minassian, Angela M; Liu, Xinxue; Snape, Matthew D

Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial

英国异源和同源新冠疫苗第三剂接种方案后免疫反应的持久性:COV-BOOST试验的八个月分析

Liu, Xinxue; Munro, Alasdair P S; Wright, Annie; Feng, Shuo; Janani, Leila; Aley, Parvinder K; Babbage, Gavin; Baker, Jonathan; Baxter, David; Bawa, Tanveer; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Fox, Lauren; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Haughney, John; Hicks, Alexander; Jones, Christine E; Kanji, Nasir; van der Klaauw, Agatha A; Libri, Vincenzo; Llewelyn, Martin J; Mansfield, Rebecca; Maallah, Mina; McGregor, Alastair C; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Belhadef, Hanane Trari; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Saralaya, Dinesh; Sharma, Sunil; Sheridan, Ray; Stokes, Matthew; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Cornelius, Victoria; Snape, Matthew D; Faust, Saul N

Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus.

针对SARS-CoV-2的加强疫苗接种可在人类免疫缺陷病毒感染者中诱导强烈的免疫反应

Fidler Sarah, Fox Julie, Tipoe Timothy, Longet Stephanie, Tipton Tom, Abeywickrema Movin, Adele Sandra, Alagaratnam Jasmini, Ali Mohammad, Aley Parvinder K, Aslam Suhail, Balasubramanian Anbhu, Bara Anna, Bawa Tanveer, Brown Anthony, Brown Helen, Cappuccini Federica, Davies Sophie, Fowler Jamie, Godfrey Leila, Goodman Anna L, Hilario Kathrine, Hackstein Carl-Philipp, Mathew Moncy, Mujadidi Yama F, Packham Alice, Petersen Claire, Plested Emma, Pollock Katrina M, Ramasamy Maheshi N, Robinson Hannah, Robinson Nicola, Rongkard Patpong, Sanders Helen, Serafimova Teona, Spence Niamh, Waters Anele, Woods Danielle, Zacharopoulou Panagiota, Barnes Eleanor, Dunachie Susanna, Goulder Philip, Klenerman Paul, Winston Alan, Hill Adrian V S, Gilbert Sarah C, Carroll Miles, Pollard Andrew J, Lambe Teresa, Ogbe Ane, Frater John

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials

接种两剂 ChAdOx1 nCov-19 (AZD1222) 后免疫反应的持久性:两项随机对照试验的 1 年随访结果

Voysey, Merryn; Flaxman, Amy; Aboagye, Jeremy; Aley, Parvinder K; Belij-Rammerstorfer, Sandra; Bibi, Sagida; Bittaye, Mustapha; Cappuccini, Federica; Charlton, Sue; Clutterbuck, Elizabeth A; Davies, Sophie; Dold, Christina; Edwards, Nick J; Ewer, Katie J; Faust, Saul N; Folegatti, Pedro M; Fowler, Jamie; Gilbride, Ciaran; Gilbert, Sarah C; Godfrey, Leila; Hallis, Bassam; Humphries, Holly E; Jenkin, Daniel; Kerridge, Simon; Mujadidi, Yama F; Plested, Emma; Ramasamy, Maheshi N; Robinson, Hannah; Sanders, Helen; Snape, Matthew D; Song, Rinn; Thomas, Kelly M; Ulaszewska, Marta; Woods, Danielle; Wright, Daniel; Pollard, Andrew J; Lambe, Teresa

Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials

已成功将新生儿基因检测纳入英国常规筛查,并采用前瞻性知情同意来确定临床试验的入组资格。

Bendor-Samuel, Owen Martyn; Wishlade, Tabitha; Willis, Louise; Aley, Parvinder; Choi, Edward; Craik, Rachel; Mujadidi, Yama; Mounce, Ginny; Roseman, Fenella; De La Horra Gozalo, Arancha; Bland, James; Taj, Nazia; Smith, Ian; Ziegler, Anette-Gabriele; Bonifacio, Ezio; Winkler, Christiane; Haupt, Florian; Todd, John A; Servais, Laurent; Snape, Matthew D; Vatish, Manu